← Back to Clinical Trials
Recruiting NCT06534372

NCT06534372 Affecting Factors for Chronic Pain After Sternotomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06534372
Status Recruiting
Phase
Sponsor Ankara Etlik City Hospital
Condition Cardiac Surgery
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2024-09-01
Primary Completion 2026-03-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL
Interventions
Open cardiac surgery with sternotomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2024-09-01 with a primary completion date of 2026-03-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Chronic pain is common complication of surgery procedures. Rates of mortalits is getting lower in cardiac surgery. This situation has brought us to focus morbidity and long term life quality. Previous study show that chronic pain after cardiac surgery is experienced 11-40% patient. Multifactorial causes play a role in chronic pain etiology. The aim of our study is to determine the causes of chronic pain in patients who underwent sternotomy.

Eligibility Criteria

Inclusion Criteria: * Between the ages of 18-80 * BMI 18-35 kg/m2 * ASA (American Society of Anesthesiologists) Scoring I-II-III * Elective open coronary artery bypass graft surgery * Elective open heart valve surgery * Patients who will undergo general anesthesia * Patients who agree to participate in the study and sign a form Exclusion Criteria: * Patients under 18 and over 80 years of age * Patients who do not want to participate in the study * Patients with advanced organ failure (liver failure, renal failure) * Patients with chronic pain or chronic opioid use * Patients with alcohol, substance or drug addiction * Patients planned for surgery with thoracotomy * Patients with a history of previous sternotomy (redo) * Patients with limited cooperation such as dementia, psychiatric disorders * Pregnant and breastfeeding patients will be excluded from the study. * Patients who cannot communicate in their native language will be excluded from the study

Contact & Investigator

Central Contact

Umut Can Özağar, M.D.

✉ ozagarumutcan@hotmail.com

📞 00905546271611

Principal Investigator

Jülide Ergil, Professor

STUDY DIRECTOR

WHO, Turkish Society of Anesthesiology and Reanimation

Frequently Asked Questions

Who can join the NCT06534372 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Cardiac Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06534372 currently recruiting?

Yes, NCT06534372 is actively recruiting participants. Contact the research team at ozagarumutcan@hotmail.com for enrollment information.

Where is the NCT06534372 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye).

Who is sponsoring the NCT06534372 clinical trial?

NCT06534372 is sponsored by Ankara Etlik City Hospital. The principal investigator is Jülide Ergil, Professor at WHO, Turkish Society of Anesthesiology and Reanimation. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology